SCHEMBL28819289

SCHEMBL28819289

O=C(Br)C(O)(c1ccccc1)c1ccccc1C(F)(F)F

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CYP2C9 P11712 1/20 0.43
▸ ALDH1A1 P00352 2/20 0.40
▸ TSHR P16473 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ NFKB1 P19838 1/20 0.39
▸ HPGD P15428 1/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ TAS2R14 Q9NYV8 1/20 0.38
▸ KCNN4 O15554 2/20 0.38
▸ PTPN1 P18031 1/20 0.37
▸ MAOB P27338 3/20 0.36
▸ POLB P06746 1/20 0.36
▸ SLC13A5 Q86YT5 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28957192 0.85 TAS2R14 (0.46) CYP2C9ALDH1A1TSHRLMNAGAA
SCHEMBL28143221 0.81 ALDH1A1 (0.54) CYP2C9ALDH1A1TSHRSMN1; SMN2PTPN1
SCHEMBL2927951 0.80 CYP2C9 (0.50) CYP2C9ALDH1A1LMNAGAASMN1; SMN2
SCHEMBL7088401 0.79 CYP2C9 (0.50) CYP2C9ALDH1A1LMNAGAANFKB1
SCHEMBL28326071 0.77 MEN1 (0.43) CYP2C9ALDH1A1LMNAGAAHPGD
SCHEMBL28960373 0.73 CYP2C9 (0.64) CYP2C9ALDH1A1TSHRMAOBMEN1
SCHEMBL7768876 0.72 ALDH1A1 (0.50) ALDH1A1TSHRLMNAGAANFKB1
SCHEMBL12264152 0.72 ALDH1A1 (0.50) CYP2C9ALDH1A1TSHRLMNAGAA
SCHEMBL7088402 0.72 CYP2C9 (0.49) CYP2C9ALDH1A1TSHRLMNAGAA
Benzylic Acid SCHEMBL7066 0.71 CYP2C9 (0.74) CYP2C9ALDH1A1TSHRLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104583208-B Can be used for treating substituted 3,4-dihydro-2H-pyrido [1,2-a] pyrazine-1,6-derovatives of (especially) Alzheimer 杨森制药公司 2016-09-28 — — CN disclosed
CN-104583208-A Substituted 3, 4-dihydro-2h-pyrido[1,2-a]pyrazine-1,6-dione derivatives useful for the treatment of (inter alia) alzheimer's disease JANSSEN PHARMACEUTICALS INC 2015-04-29 — — CN disclosed
Send feedback